Does TRT-induced erythrocytosis actually increase venous thromboembolism risk in clinical practice?
Analysis ID: SDA-2026-04-13-gap-pubmed-20260410-155308-2c6815fb | Domain: endocrinology | Status: failed | Created: 2026-04-13T14:49:50.926431
Top Hypotheses (2 total)
#1 EPO Set Point Calibration Hypothesis
0.572
Dynamic EPO Monitoring as a Predictive Biomarker for Individualized VTE Risk Assessment in TRT. Men whose EPO fails to appropriately normalize despite elevated hematocrit represent a high-VTE-risk phe
#2 Hepcidin-Iron Set Point Hypothesis
0.511
# The Hepcidin-Iron Set Point Hypothesis: Targeted Suppression of Hepcidin to Prevent Testosterone Replacement Therapy–Induced Erythrocytosis While Preserving Neuroprotective Erythropoietic Benefits